• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤相关巨噬细胞通过程序性死亡受体1(PD-1)信号通路促进肿瘤内常规CD4 T细胞向调节性T细胞转化。

Tumor-associated macrophages promote intratumoral conversion of conventional CD4 T cells into regulatory T cells via PD-1 signalling.

作者信息

Kos Kevin, Salvagno Camilla, Wellenstein Max D, Aslam Muhammad A, Meijer Denize A, Hau Cheei-Sing, Vrijland Kim, Kaldenbach Daphne, Raeven Elisabeth A M, Schmittnaegel Martina, Ries Carola H, de Visser Karin E

机构信息

Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.

Oncode Institute, Utrecht, The Netherlands.

出版信息

Oncoimmunology. 2022 Apr 15;11(1):2063225. doi: 10.1080/2162402X.2022.2063225. eCollection 2022.

DOI:10.1080/2162402X.2022.2063225
PMID:35481289
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9037432/
Abstract

While regulatory T cells (T) and macrophages have been recognized as key orchestrators of cancer-associated immunosuppression, their cellular crosstalk within tumors has been poorly characterized. Here, using spontaneous models for breast cancer, we demonstrate that tumor-associated macrophages (TAMs) contribute to the intratumoral accumulation of T by promoting the conversion of conventional CD4 T cells (T) into T. Mechanistically, two processes were identified that independently contribute to this process. While TAM-derived TGF-β directly promotes the conversion of CD4 T into T, we additionally show that TAMs enhance PD-1 expression on CD4 T cells. This indirectly contributes to the intratumoral accumulation of T, as loss of PD-1 on CD4 T abrogates intratumoral conversion of adoptively transferred CD4 T into T. Combined, this study provides insights into the complex immune cell crosstalk between CD4 T cells and TAMs in the tumor microenvironment of breast cancer, and further highlights that therapeutic exploitation of macrophages may be an attractive immune intervention to limit the accumulation of T in breast tumors.

摘要

虽然调节性T细胞(Treg)和巨噬细胞已被公认为癌症相关免疫抑制的关键协调者,但它们在肿瘤内的细胞间相互作用却鲜有描述。在此,我们利用乳腺癌自发模型证明,肿瘤相关巨噬细胞(TAM)通过促进常规CD4 T细胞(Th)转化为Treg,促进了Treg在肿瘤内的积累。从机制上来说,我们确定了两个独立促成这一过程的机制。虽然TAM衍生的转化生长因子-β(TGF-β)直接促进CD4 Th细胞转化为Treg,但我们还表明,TAM会增强CD4 T细胞上程序性死亡受体1(PD-1)的表达。这间接促成了Treg在肿瘤内的积累,因为CD4 T细胞上PD-1的缺失消除了过继转移的CD4 Th细胞在肿瘤内转化为Treg的过程。综合来看,本研究深入探讨了乳腺癌肿瘤微环境中CD4 T细胞与TAM之间复杂的免疫细胞相互作用,并进一步强调,对巨噬细胞进行治疗性利用可能是一种有吸引力的免疫干预手段,可限制Treg在乳腺肿瘤中的积累。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98b2/9037432/6272b049f06d/KONI_A_2063225_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98b2/9037432/68b561c2705e/KONI_A_2063225_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98b2/9037432/4c06fed1e99d/KONI_A_2063225_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98b2/9037432/8a96a9478e61/KONI_A_2063225_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98b2/9037432/96bf3ae97992/KONI_A_2063225_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98b2/9037432/6272b049f06d/KONI_A_2063225_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98b2/9037432/68b561c2705e/KONI_A_2063225_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98b2/9037432/4c06fed1e99d/KONI_A_2063225_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98b2/9037432/8a96a9478e61/KONI_A_2063225_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98b2/9037432/96bf3ae97992/KONI_A_2063225_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98b2/9037432/6272b049f06d/KONI_A_2063225_F0005_OC.jpg

相似文献

1
Tumor-associated macrophages promote intratumoral conversion of conventional CD4 T cells into regulatory T cells via PD-1 signalling.肿瘤相关巨噬细胞通过程序性死亡受体1(PD-1)信号通路促进肿瘤内常规CD4 T细胞向调节性T细胞转化。
Oncoimmunology. 2022 Apr 15;11(1):2063225. doi: 10.1080/2162402X.2022.2063225. eCollection 2022.
2
Analysis of the T-cell receptor repertoires of tumor-infiltrating conventional and regulatory T cells reveals no evidence for conversion in carcinogen-induced tumors.分析肿瘤浸润常规 T 细胞和调节性 T 细胞的 T 细胞受体库,未发现致癌物诱导肿瘤中发生转化的证据。
Cancer Res. 2011 Feb 1;71(3):736-46. doi: 10.1158/0008-5472.CAN-10-1797. Epub 2010 Dec 13.
3
Blocking the recruitment of naive CD4 T cells reverses immunosuppression in breast cancer.阻断初始CD4 T细胞的募集可逆转乳腺癌中的免疫抑制。
Cell Res. 2017 Apr;27(4):461-482. doi: 10.1038/cr.2017.34. Epub 2017 Mar 14.
4
Aiduqing formula inhibits breast cancer metastasis by suppressing TAM/CXCL1-induced Treg differentiation and infiltration.艾杜清方通过抑制 TAM/CXCL1 诱导的 Treg 分化和浸润来抑制乳腺癌转移。
Cell Commun Signal. 2021 Aug 30;19(1):89. doi: 10.1186/s12964-021-00775-2.
5
TGF-β1-Induced SOX18 Elevation Promotes Hepatocellular Carcinoma Progression and Metastasis Through Transcriptionally Upregulating PD-L1 and CXCL12.TGF-β1 诱导的 SOX18 升高通过转录上调 PD-L1 和 CXCL12 促进肝细胞癌的进展和转移。
Gastroenterology. 2024 Jul;167(2):264-280. doi: 10.1053/j.gastro.2024.02.025. Epub 2024 Feb 27.
6
Blocking Triggering Receptor Expressed on Myeloid Cells-1-Positive Tumor-Associated Macrophages Induced by Hypoxia Reverses Immunosuppression and Anti-Programmed Cell Death Ligand 1 Resistance in Liver Cancer.阻断低氧诱导的表达在髓系细胞上的触发受体 1 阳性肿瘤相关巨噬细胞可逆转肝癌中的免疫抑制和抗程序性细胞死亡配体 1 耐药性。
Hepatology. 2019 Jul;70(1):198-214. doi: 10.1002/hep.30593. Epub 2019 Apr 12.
7
Targeting tumor-infiltrating CCR8 regulatory T cells induces antitumor immunity through functional restoration of CD4 T and CD8 T cells in colorectal cancer.靶向肿瘤浸润性 CCR8 调节性 T 细胞通过恢复结直肠癌中 CD4 T 和 CD8 T 细胞的功能诱导抗肿瘤免疫。
J Transl Med. 2024 Jul 30;22(1):709. doi: 10.1186/s12967-024-05518-8.
8
Tumor-associated macrophages and the tumor immune microenvironment of primary and recurrent epithelial ovarian cancer.原发性和复发性上皮性卵巢癌中的肿瘤相关巨噬细胞和肿瘤免疫微环境。
Hum Pathol. 2018 Apr;74:135-147. doi: 10.1016/j.humpath.2017.12.010. Epub 2017 Dec 27.
9
Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.基质 PD-L1 阳性调节性 T 细胞和 PD-1 阳性 CD8 阳性 T 细胞定义了不同亚组非小细胞肺癌对 PD-1/PD-L1 阻断免疫治疗的反应。
J Thorac Oncol. 2018 Apr;13(4):521-532. doi: 10.1016/j.jtho.2017.11.132. Epub 2017 Dec 18.
10
Blockade of surface-bound TGF-β on regulatory T cells abrogates suppression of effector T cell function in the tumor microenvironment.阻断调节性 T 细胞表面结合的 TGF-β 可消除肿瘤微环境中效应 T 细胞功能的抑制。
Sci Signal. 2017 Aug 29;10(494):eaak9702. doi: 10.1126/scisignal.aak9702.

引用本文的文献

1
Breast Cancer and Tumor Microenvironment: The Crucial Role of Immune Cells.乳腺癌与肿瘤微环境:免疫细胞的关键作用
Curr Oncol. 2025 Feb 28;32(3):143. doi: 10.3390/curroncol32030143.
2
Analysis of ferritinophagy-related genes associated with the prognosis and regulatory mechanisms in non-small cell lung cancer.非小细胞肺癌中铁自噬相关基因与预后及调控机制的分析
Front Med (Lausanne). 2025 Mar 7;12:1480169. doi: 10.3389/fmed.2025.1480169. eCollection 2025.
3
Evaluating the prognostic potential of telomerase signature in breast cancer through advanced machine learning model.

本文引用的文献

1
Tumor-educated T drive organ-specific metastasis in breast cancer by impairing NK cells in the lymph node niche.肿瘤教育的 T 细胞通过破坏淋巴结龛位中的 NK 细胞驱动乳腺癌的器官特异性转移。
Cell Rep. 2022 Mar 1;38(9):110447. doi: 10.1016/j.celrep.2022.110447.
2
The Multifaceted Role of Regulatory T Cells in Breast Cancer.调节性T细胞在乳腺癌中的多方面作用
Annu Rev Cancer Biol. 2021 Mar;5:291-310. doi: 10.1146/annurev-cancerbio-042920-104912. Epub 2020 Dec 4.
3
Overcoming microenvironmental resistance to PD-1 blockade in genetically engineered lung cancer models.
通过先进的机器学习模型评估端粒酶特征在乳腺癌中的预后潜力。
Front Immunol. 2024 Nov 28;15:1462953. doi: 10.3389/fimmu.2024.1462953. eCollection 2024.
4
Targeting of TAMs: can we be more clever than cancer cells?靶向肿瘤相关巨噬细胞:我们能否比癌细胞更聪明?
Cell Mol Immunol. 2024 Dec;21(12):1376-1409. doi: 10.1038/s41423-024-01232-z. Epub 2024 Nov 8.
5
Distinct characteristics of BTLA/HVEM axis expression on Tregs and its impact on the expansion and attributes of Tregs in patients with active pulmonary tuberculosis.调节性 T 细胞上 BTLA/HVEM 轴表达的独特特征及其对活动性肺结核患者调节性 T 细胞扩增和表型的影响。
Front Cell Infect Microbiol. 2024 Sep 25;14:1437207. doi: 10.3389/fcimb.2024.1437207. eCollection 2024.
6
Overcoming fixation and permeabilization challenges in flow cytometry by optical barcoding and multi-pass acquisition.通过光学条形码和多通道采集克服流式细胞术中的固定和通透化挑战。
bioRxiv. 2024 Aug 16:2024.08.13.607771. doi: 10.1101/2024.08.13.607771.
7
Biophysical and biochemical aspects of immune cell-tumor microenvironment interactions.免疫细胞与肿瘤微环境相互作用的生物物理和生化方面
APL Bioeng. 2024 Apr 2;8(2):021502. doi: 10.1063/5.0195244. eCollection 2024 Jun.
8
Immune cell networking in solid tumors: focus on macrophages and neutrophils.实体瘤中的免疫细胞网络:聚焦于巨噬细胞和中性粒细胞。
Front Immunol. 2024 Feb 14;15:1341390. doi: 10.3389/fimmu.2024.1341390. eCollection 2024.
9
Long Non-Coding RNAs in Colorectal Cancer: Navigating the Intersections of Immunity, Intercellular Communication, and Therapeutic Potential.结直肠癌中的长链非编码RNA:探索免疫、细胞间通讯及治疗潜力的交叉点
Biomedicines. 2023 Aug 28;11(9):2411. doi: 10.3390/biomedicines11092411.
10
High infiltration of CD209 dendritic cells and CD163 macrophages in the peritumor area of prostate cancer is predictive of late adverse outcomes.前列腺癌肿瘤周围区域中 CD209 树突状细胞和 CD163 巨噬细胞的高浸润与晚期不良预后相关。
Front Immunol. 2023 Jun 26;14:1205266. doi: 10.3389/fimmu.2023.1205266. eCollection 2023.
克服基因工程肺癌模型中 PD-1 阻断的微环境抵抗。
Sci Transl Med. 2021 Aug 11;13(606). doi: 10.1126/scitranslmed.abd1616.
4
Tumor-Associated Macrophages: A Potential Target for Cancer Therapy.肿瘤相关巨噬细胞:癌症治疗的潜在靶点。
Front Oncol. 2021 Jun 10;11:693517. doi: 10.3389/fonc.2021.693517. eCollection 2021.
5
Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cells.组织驻留巨噬细胞为早期 NSCLC 细胞提供促肿瘤发生的生态位。
Nature. 2021 Jul;595(7868):578-584. doi: 10.1038/s41586-021-03651-8. Epub 2021 Jun 16.
6
The Ig heavy chain protein but not its message controls early B cell development.Ig 重链蛋白而非其信使 RNA 控制早期 B 细胞发育。
Proc Natl Acad Sci U S A. 2020 Dec 8;117(49):31343-31352. doi: 10.1073/pnas.2004810117. Epub 2020 Nov 23.
7
Targeting Tumor-Associated Macrophages to Increase the Efficacy of Immune Checkpoint Inhibitors: A Glimpse into Novel Therapeutic Approaches for Metastatic Melanoma.靶向肿瘤相关巨噬细胞以提高免疫检查点抑制剂的疗效:转移性黑色素瘤新型治疗方法一瞥
Cancers (Basel). 2020 Nov 17;12(11):3401. doi: 10.3390/cancers12113401.
8
The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies.效应 T 细胞和调节性 T 细胞之间的 PD-1 表达平衡可预测 PD-1 阻断疗法的临床疗效。
Nat Immunol. 2020 Nov;21(11):1346-1358. doi: 10.1038/s41590-020-0769-3. Epub 2020 Aug 31.
9
Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine.阻断 AHR 可限制由 L-犬尿酸诱导的 Treg-巨噬细胞抑制轴。
Nat Commun. 2020 Aug 11;11(1):4011. doi: 10.1038/s41467-020-17750-z.
10
Visualizing and interpreting cancer genomics data via the Xena platform.通过Xena平台可视化和解读癌症基因组学数据。
Nat Biotechnol. 2020 Jun;38(6):675-678. doi: 10.1038/s41587-020-0546-8.